| Financial Year |
March 31 2023 |
| Monetary Funds |
2,780,232,790.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
14,044,043.89 |
| Advances to Suppliers |
147,959,998.85 |
| Other Receivables |
38,923,765.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
428,135,726.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,816,562.57 |
| Total Current Assets |
3,430,112,888.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,368,971.28 |
| Investment Properties |
454,050,712.00 |
| Fixed Assetes |
299,805,506.40 |
| Under-construction Projects |
348,028,627.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
21,603,640.50 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
162,912,668.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,402,942.62 |
| Deferred Income Tax Assets |
10,514,576.36 |
| Other Non-Current Assets |
2,131,253.58 |
| Sub-Total of Non-Current Assets |
2,540,901,065.95 |
| Total Assets |
5,971,013,954.10 |
| Short-Term Loans |
1,369,855,961.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,633,655.32 |
| Accounts Payable |
80,707,172.08 |
| Accounts Received In Advance |
7,698,503.70 |
| Employee Compensation Payable |
20,035,809.20 |
| Taxes Payable |
6,993,642.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
69,115,832.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,583,241.45 |
| Other Current Liabilities |
9,491,403.19 |
| Sub-Total of Current Liabilities |
1,726,803,730.21 |
| Long-term Loans |
421,168,359.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
277,921,428.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,177,514,761.99 |
| Total Liabilities |
2,904,318,492.20 |
| Paid-In Capital(Or Share Stock) |
583,790,330.00 |
| Capital Surplus |
418,245,612.26 |
| Surplus Reserve |
584,082,917.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,418,022,281.05 |
| Minority Stockholder's Interest |
33,449,570.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,033,245,890.93 |
| Owner's Equity（Stockholder's Equity） |
3,066,695,461.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,971,013,954.10 |
